These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 25900517

  • 1. The improved efficacy of a fixed-dose combination of fluticasone furoate and levocabastine relative to the individual components in the treatment of allergic rhinitis.
    Murdoch RD, Bareille P, Ignar D, Miller SR, Gupta A, Boardley R, Zieglmayer P, Zieglmayer R, Lemel P, Horak F.
    Clin Exp Allergy; 2015 Aug; 45(8):1346-55. PubMed ID: 25900517
    [Abstract] [Full Text] [Related]

  • 2. Once-daily dosing of levocabastine has comparable efficacy to twice-daily dosing in the treatment of allergic rhinitis assessed in an allergen challenge chamber.
    Murdoch RD, Bareille P, Ignar D, Mark S, Miller SR, Gupta A, Salapatek AM, Patel P.
    Int J Clin Pharmacol Ther; 2015 Oct; 53(10):811-8. PubMed ID: 26249767
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics, Safety, and Tolerability of Once-Daily Intranasal Fluticasone Furoate and Levocabastine Administered Alone or Simultaneously as fluticasone Furoate/Levocabastine Fixed-Dose Combination.
    Allen A, Murdoch RD, Bareille P, Burns O, Hughes S, Gupta A, Miller SR.
    Clin Pharmacol Drug Dev; 2016 May; 5(3):225-31. PubMed ID: 27163502
    [Abstract] [Full Text] [Related]

  • 4. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber.
    Zieglmayer P, Zieglmayer R, Bareille P, Rousell V, Salmon E, Horak F.
    Curr Med Res Opin; 2008 Jun; 24(6):1833-40. PubMed ID: 18498678
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R, Martin B, Hampel F, Toler W, Ellsworth A, Philpot E.
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [Abstract] [Full Text] [Related]

  • 6. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
    Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkauskiene B, van Oene C, Faris MA, Ellsworth A, Caldwell MF.
    Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [Abstract] [Full Text] [Related]

  • 8. An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis.
    Maspero JF, Walters RD, Wu W, Philpot EE, Naclerio RM, Fokkens WJ.
    Allergy Asthma Proc; 2010 Jan; 31(6):483-92. PubMed ID: 21708060
    [Abstract] [Full Text] [Related]

  • 9. A Real-World Observational Study to Evaluate the Safety and Effectiveness of Fluticasone Furoate-Oxymetazoline Fixed Dose Combination Nasal Spray in Patients with Allergic Rhinitis.
    Juvekar MR, Vaidya GK, Majumder A, Pendharkar AD, Irudhayarajan A, Kundu A, Ramesh D, Kumar JD, Jagannatha B, Mathew J, Nikam MP, Mehta M, Chawla N, Hajare P, Gowda PGC, Murthy PVLN, Mathew SM, Damle MV, Kant C, Nair AB, Jaiswal A, Mehta RT.
    Clin Drug Investig; 2024 Feb; 44(2):123-130. PubMed ID: 38195833
    [Abstract] [Full Text] [Related]

  • 10. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [Abstract] [Full Text] [Related]

  • 11. The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis.
    Bareille P, Murdoch RD, Denyer J, Bentley J, Smart K, Yarnall K, Zieglmayer P, Zieglmayer R, Lemell P, Horak F.
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):576-84. PubMed ID: 23735181
    [Abstract] [Full Text] [Related]

  • 12. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC, Ratner PH, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [Abstract] [Full Text] [Related]

  • 13. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.
    Nathan RA, Berger W, Yang W, Cheema A, Silvey M, Wu W, Philpot E.
    Ann Allergy Asthma Immunol; 2008 May; 100(5):497-505. PubMed ID: 18517084
    [Abstract] [Full Text] [Related]

  • 14. An open label, active controlled, multicentric clinical trial to assess the efficacy and safety of fluticasone furoate nasal spray in adult Indian patients suffering from allergic rhinitis.
    Kubavat AH, Pawar P, Mittal R, Sinha V, Shah UB, Ojha T, Khippal N, Patel T.
    J Assoc Physicians India; 2011 Jul; 59():424-8. PubMed ID: 22315746
    [Abstract] [Full Text] [Related]

  • 15. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.
    Kaiser HB, Naclerio RM, Given J, Toler TN, Ellsworth A, Philpot EE.
    J Allergy Clin Immunol; 2007 Jun; 119(6):1430-7. PubMed ID: 17418384
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H, Orozco S, Allen A.
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [Abstract] [Full Text] [Related]

  • 17. Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms.
    Baroody FM, Logothetis H, Vishwanath S, Bashir M, Detineo M, Naclerio RM.
    Am J Rhinol Allergy; 2013 Jan; 27(1):48-53. PubMed ID: 23406601
    [Abstract] [Full Text] [Related]

  • 18. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M, Nolop K, Lutsky BN.
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
    [Abstract] [Full Text] [Related]

  • 19. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.
    Anolik R, Mometasone Furoate Nasal Spray With Loratadine Study Group.
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):264-71. PubMed ID: 18426147
    [Abstract] [Full Text] [Related]

  • 20. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.
    Bernstein DI, Levy AL, Hampel FC, Baidoo CA, Cook CK, Philpot EE, Rickard KA.
    Clin Exp Allergy; 2004 Jun; 34(6):952-7. PubMed ID: 15196285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.